Cefpodoxime proxetil
CAS: 87239-81-4
Ref. 3D-FC19867
2g | 327.00 € | ||
5g | 461.00 € | ||
10g | 547.00 € | ||
50g | 1,042.00 € | ||
100g | 1,226.00 € |
Product Information
- (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2 -carboxylic Acid 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl Ester
- (Rs)-1(Isopropoxycarbonyloxy)Ethyl (+)-(6R,7R)-7-[2-(2-Amino-4-Thiazolyl)-2-[(Z)Methoxyimino]Acetamido]-3-Methoxymethyl-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylate
- 1-{[(1-methylethoxy)carbonyl]oxy}ethyl (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 1-{[(1-methylethoxy)carbonyl]oxy}ethyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 1-{[(1-methylethoxy)carbonyl]oxy}ethyl 7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, [6R-[6α,7β(Z)]]-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, (6R,7R)-
- Antibiotic CS 807
- Banan
- See more synonyms
- CS 807 (pharmaceutical)
- Cefodox
- Cefoflam
- Cefoprox
- Cefpodoxime
- Cephpodoxime proxetil
- Cepodem
- Cs 807
- Orelox
- Otreon
- Ru 51807
- Simplicef
- U 76252
- Vantin
Cefpodoxime is a cephalosporin antibiotic that is used to treat various infections, such as streptococcal pharyngitis and other bacterial infections. It is an oral prodrug that needs to be converted in the body to its active form, cefpodoxime. Cefpodoxime binds to the bacterial ribosome and prevents the formation of peptidoglycan cross-links in the cell wall, which inhibits bacterial growth. It has been shown to have a broad spectrum of activity against gram-positive species, including Streptococcus species. Cefpodoxime can interact with other drugs and should not be taken with antacids or laxatives containing magnesium.
Cefpodoxime proxetil has been found to be biocompatible and can be used for prolonging drug release in devices such as implants or stents.
Chemical properties
Technical inquiry about: 3D-FC19867 Cefpodoxime proxetil
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.